FDG PET/CT 用于检测实体器官移植后感染并发症
本文为文献综述,检索 PubMed、Medline 和 Cochrane 数据库,纳入 13 篇文章和 46 例病例报告,评估 FDG PET/CT 在实体器官移植后感染并发症中的应用。综述认为,在缺乏初始诊断线索时,FDG PET/CT 可作为首选影像技术,可指导进一步检查并最终明确多数患者诊断;但现有文献 scarce,需设计良好的前瞻性对照研究确立其作用。FDG PET/CT 主要缺点是无法区分肿瘤与感染性疾病,二者在该人群均高发,假阳性主要源于将良性炎症或感染过程误诊为癌症。
要点
- 缺乏初始诊断线索时,FDG PET/CT 可考虑作为首选影像技术。
- FDG PET/CT 可指导进一步检查并最终明确多数患者诊断。
- 现有文献 scarce,需前瞻性对照研究确立其作用。
核心结论
- 在缺乏初始诊断线索时,FDG PET/CT 应被视为首选影像技术,可指导进一步检查并最终揭示多数患者的诊断。
- 现有关于 FDG PET/CT 在实体器官移植受者感染并发症中作用的文献 scarce,需设计良好的前瞻性对照研究确立其作用。
研究设计与样本
- 本文为文献综述,检索 PubMed、Medline 和 Cochrane 数据库,最终检索于 2020 年 9 月 2 日进行。
- 共纳入 13 篇文章和 46 例病例报告,纳入标准为包含实体器官移植后感染并发症患者数据且 FDG PET/CT 为检查流程的一部分。
主要发现
- 在缺乏初始诊断线索时,FDG PET/CT 可指导进一步检查并最终揭示多数患者的诊断。
- FDG PET/CT 的主要缺点是无法区分癌症与感染性疾病,二者在该患者群体中均高发。
- FDG PET/CT 假阳性的主要原因是将良性炎症或感染过程误诊为癌症,但该信息仍可能有用。
临床怎么用
- 在实体器官移植后感染并发症且缺乏初始诊断线索时,可考虑将 FDG PET/CT 作为首选影像技术。
- 应用 FDG PET/CT 时需注意其无法区分肿瘤与感染性疾病,应结合临床警惕假阳性。
局限性
- 现有关于 FDG PET/CT 在实体器官移植受者感染并发症中作用的文献 scarce。
- 需设计良好的前瞻性研究(包括对照组)来确立 FDG PET/CT 在该人群中的作用。
- FDG PET/CT 无法区分癌症与感染性疾病,二者在该患者群体中均高发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Infectious complications after solid organ transplantation (SOT) are often more severe and remain a diagnostic challenge due to vague and atypical clinical presentations. Diagnostic performance of conventional diagnostic tools is frequently inadequate which may lead to delayed diagnosis with the risk of poorer outcomes. This literature review aimed to investigate the current evidence on the use of 18F-fluoro-deoxy-glucose (FDG) Positron Emission Tomography (PET)/computer tomography (CT) in infectious complications after SOT. Based on search in PubMed, Medline, and Cochrane databases, 13 articles and 46 case reports were included. For inclusion, articles were to include data on patients with infectious complications after SOT, and where FDG PET/CT was part of the work-up. Final searches were conducted on 02 September 2020. Overall, in the absence of initial diagnostic clues, FDG PET/CT should be considered as the imaging technique of choice as it may guide further investigations and eventually reveal the diagnosis in most of the patients. However, the available literature of the role of FDG PET/CT in SOT recipients with infectious complications is scarce and well-designed prospective studies including control groups are warranted to establish the role of FDG PET/C/ in SOT recipients. The main drawback of FDG PET/CT is the lack of ability to differentiate between cancer and infectious diseases which are both highly prevalent in this patient group. Accordingly, the main reasons for "false" results of FDG PET/CT is the misdiagnosis of cancer in benign inflammatory or infectious processes, information which nonetheless can be useful.
引用
- Wareham NE, Nielsen SD, Sørensen SS, et al. FDG PET/CT for Detection of Infectious Complications Following Solid Organ Transplantation. Semin Nucl Med. 2021. PMID: 33397588. doi:10.1053/j.semnuclmed.2020.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。